Parabilis Medicines, Inc. (NASDAQ:PBLS – Get Free Report) Director Alan Sebulsky acquired 9,065 shares of the stock in a transaction that occurred on Monday, June 15th. The stock was purchased at an average price of $26.49 per share, for a total transaction of $240,131.85. Following the completion of the transaction, the director owned 30,000 shares in the company, valued at $794,700. The trade was a 43.30% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link.
Alan Sebulsky also recently made the following trade(s):
- On Friday, June 12th, Alan Sebulsky acquired 8,435 shares of Parabilis Medicines stock. The stock was purchased at an average price of $27.67 per share, for a total transaction of $233,396.45.
- On Thursday, June 11th, Alan Sebulsky acquired 12,500 shares of Parabilis Medicines stock. The stock was purchased at an average price of $20.00 per share, for a total transaction of $250,000.00.
Parabilis Medicines Price Performance
NASDAQ:PBLS opened at $26.03 on Thursday. Parabilis Medicines, Inc. has a 1-year low of $24.51 and a 1-year high of $34.47.
See Also
- Five stocks we like better than Parabilis Medicines
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Receive News & Ratings for Parabilis Medicines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parabilis Medicines and related companies with MarketBeat.com's FREE daily email newsletter.
